Clinical trial

Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery…

NCT00333164 · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other · Completed

Key facts

NCT number NCT00333164
Title Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis
Official title Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis (CATHARSIS)
Lead sponsor Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other
Collaborators Foundation for Biomedical Research and Innovation Neurology, Tokyo Women's Medical University, School of Medicine Kobe City General Hospital Tohoku University Kyushu University Department of…
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cerebrovascular Disease
Intervention type Drug
Interventions Asprin, Cilostazol
Enrollment 200
Start date May 1, 2006
Primary completion Mar 1, 2012
Completion Mar 1, 2012
First posted Jun 2, 2006
Last update posted Dec 19, 2017
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies